PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsParkinson disease
MeSH D010300 - parkinson disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D020734:Parkinsonian disorders
1 Company
1 Drug
$
Success rate
D000080874:Synucleinopathies
0 Companies
0 Drugs
Success rate
D010300: 
Parkinson disease
106 Companies
25 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
1 A PharmaRivastigmine Rivastigmine 1 A Pharma  2009-12-11   
Abbott BiotherapeuticsApomorphine Taluvian  2001-05-28   
Apomorphine Uprima  2001-05-28   
AbbVieLevodopa, Carbidopa Duopa  2015-01-09 $463 M Q1/23-Q2/24 
Acadia PharmaceuticalsPimavanserin Nuplazid 2022-07-27 2016-04-29   
Accord HealthcareLevodopa, Carbidopa Carbidopa Levodopa  2013-02-08   
Pramipexole Pramipexole Accord  2011-09-29   
Ropinirole Ropinirole  2017-02-28   
Acorda TherapeuticsLevodopa Inbrija  2019-09-19 $5.974 M Q2/23-Q1/24 
Ajanta PharmaEntacapone Entacapone  2017-08-31   
Alembic PharmaceuticalsAmantadine Amantadine  2017-06-21   
Levodopa, Carbidopa Carbidopa Levodopa  2019-06-05   
Entacapone Entacapone  2022-01-04   
Pramipexole Pramipexole  2010-10-08   
Ropinirole Ropinirole  2010-03-24   
Alkem LaboratoriesRasagiline Rasagiline  2017-10-30   
AllerganAmantadine Amantadine  1987-01-21   
Cabergoline Cabergoline  2008-04-21   
Levodopa, Carbidopa Carbidopa Levodopa  1993-09-28   
Pramipexole Pramipexole  2016-04-21   
Rasagiline Rasagiline  2013-07-01   
Rivastigmine Rivastigmine Actavis  2011-06-16   
Ropinirole Ropinirole  2012-05-17   
1
2
3
4
5
6
...
11
>
Clinical Trials
Historical Success Rate
Phase 1
64%
62/97
Phase 2
46%
72/155
Phase 3
59%
64/108
Approved: 33Overall Success rate: 18%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Dexpramipexole,
Pardoprunox,
Duodopa,
Lcig,
Ipx066
AbbVie
Levodopa,
Carbidopa,
Antithrombin iii,
Foslevodopa,
Pegargiminase,
Sodium lactate,
Microcrystalline cellulose,
Duodopa,
Lcig,
Arm1,
Arm2,
Bolus,
Ipx066,
Evidence
Acadia Pharmaceuticals
Pimavanserin,
Tartrate
Acorda Therapeutics
Levodopa,
Tozadenant,
LANDIPIRDINE,
Ipx066,
Kcl
Allergan
Levodopa,
Sodium chloride,
Azzalure
1
2
3
4
5
6
...
8
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use